Translate Bio, Inc. clinical trials
Acquired by Sanofi, Sep 14, 2021 · source ↗
The registry lists 1 studies whose lead sponsor is Translate Bio, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 17, 2019.
- 1study on the registry
- 0open to participants now
Before and after it joined Sanofi
- First submitted before Translate Bio, Inc. became part of Sanofi
- 1
- First submitted after Translate Bio, Inc. became part of Sanofi
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Stopped early1100%
Over the years
- 119
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Translate Bio, Inc.1 study
Something wrong with this grouping? Tell us on the Sanofi page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Sanofi studies →
- Safety, Tolerability and PK/PD Evaluation of Intravenous Administration of MRT5201 in Patients With OTC DeficiencyWithdrawnNCT03767270Phase 1/2
Sponsor listed in the registry: Translate Bio, Inc. · First submitted before Translate Bio, Inc. became part of Sanofi